nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—VDR—parathyroid gland—nephrolithiasis	0.102	0.236	CbGeAlD
Paricalcitol—CYP24A1—nephron tubule—nephrolithiasis	0.0389	0.0904	CbGeAlD
Paricalcitol—CYP24A1—renal system—nephrolithiasis	0.0353	0.0821	CbGeAlD
Paricalcitol—UGT1A4—renal system—nephrolithiasis	0.0353	0.0821	CbGeAlD
Paricalcitol—CYP24A1—kidney—nephrolithiasis	0.0341	0.0794	CbGeAlD
Paricalcitol—UGT1A4—kidney—nephrolithiasis	0.0341	0.0794	CbGeAlD
Paricalcitol—CYP24A1—cortex of kidney—nephrolithiasis	0.0333	0.0773	CbGeAlD
Paricalcitol—CYP24A1—Vitamin D Metabolism—PTH—nephrolithiasis	0.0303	0.338	CbGpPWpGaD
Paricalcitol—CYP3A4—urine—nephrolithiasis	0.0266	0.0618	CbGeAlD
Paricalcitol—VDR—Vitamin D Metabolism—PTH—nephrolithiasis	0.0254	0.283	CbGpPWpGaD
Paricalcitol—VDR—nephron tubule—nephrolithiasis	0.0214	0.0498	CbGeAlD
Paricalcitol—VDR—renal system—nephrolithiasis	0.0194	0.0452	CbGeAlD
Paricalcitol—VDR—kidney—nephrolithiasis	0.0188	0.0437	CbGeAlD
Paricalcitol—VDR—cortex of kidney—nephrolithiasis	0.0183	0.0426	CbGeAlD
Paricalcitol—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0272	CcSEcCtD
Paricalcitol—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0125	0.026	CcSEcCtD
Paricalcitol—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0257	CcSEcCtD
Paricalcitol—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0241	CcSEcCtD
Paricalcitol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0239	CcSEcCtD
Paricalcitol—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0232	CcSEcCtD
Paricalcitol—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0219	CcSEcCtD
Paricalcitol—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00971	0.0202	CcSEcCtD
Paricalcitol—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00967	0.0201	CcSEcCtD
Paricalcitol—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00924	0.0192	CcSEcCtD
Paricalcitol—Thirst—Hydrochlorothiazide—nephrolithiasis	0.009	0.0187	CcSEcCtD
Paricalcitol—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00882	0.0184	CcSEcCtD
Paricalcitol—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00857	0.0178	CcSEcCtD
Paricalcitol—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0085	0.0177	CcSEcCtD
Paricalcitol—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0161	CcSEcCtD
Paricalcitol—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00772	0.0161	CcSEcCtD
Paricalcitol—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00758	0.0158	CcSEcCtD
Paricalcitol—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0154	CcSEcCtD
Paricalcitol—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0154	CcSEcCtD
Paricalcitol—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00726	0.0151	CcSEcCtD
Paricalcitol—UGT1A4—Phase II conjugation—SLC26A1—nephrolithiasis	0.00722	0.0805	CbGpPWpGaD
Paricalcitol—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00688	0.0143	CcSEcCtD
Paricalcitol—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00682	0.0142	CcSEcCtD
Paricalcitol—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0138	CcSEcCtD
Paricalcitol—CYP3A4—renal system—nephrolithiasis	0.0065	0.0151	CbGeAlD
Paricalcitol—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00642	0.0134	CcSEcCtD
Paricalcitol—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00642	0.0134	CcSEcCtD
Paricalcitol—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00633	0.0132	CcSEcCtD
Paricalcitol—CYP3A4—kidney—nephrolithiasis	0.00628	0.0146	CbGeAlD
Paricalcitol—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00623	0.013	CcSEcCtD
Paricalcitol—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0062	0.0129	CcSEcCtD
Paricalcitol—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0123	CcSEcCtD
Paricalcitol—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00588	0.0122	CcSEcCtD
Paricalcitol—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00584	0.0122	CcSEcCtD
Paricalcitol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0053	0.011	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00528	0.0589	CbGpPWpGaD
Paricalcitol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00524	0.0109	CcSEcCtD
Paricalcitol—Tension—Hydrochlorothiazide—nephrolithiasis	0.00506	0.0105	CcSEcCtD
Paricalcitol—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00505	0.0105	CcSEcCtD
Paricalcitol—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00501	0.0104	CcSEcCtD
Paricalcitol—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00499	0.0104	CcSEcCtD
Paricalcitol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00496	0.0103	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00481	0.0537	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00479	0.00997	CcSEcCtD
Paricalcitol—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00993	CcSEcCtD
Paricalcitol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00987	CcSEcCtD
Paricalcitol—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00472	0.00982	CcSEcCtD
Paricalcitol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00969	CcSEcCtD
Paricalcitol—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00464	0.00965	CcSEcCtD
Paricalcitol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00963	CcSEcCtD
Paricalcitol—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00962	CcSEcCtD
Paricalcitol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00456	0.00949	CcSEcCtD
Paricalcitol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00944	CcSEcCtD
Paricalcitol—Cough—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00938	CcSEcCtD
Paricalcitol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00915	CcSEcCtD
Paricalcitol—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00915	CcSEcCtD
Paricalcitol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00915	CcSEcCtD
Paricalcitol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00911	CcSEcCtD
Paricalcitol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00904	CcSEcCtD
Paricalcitol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00895	CcSEcCtD
Paricalcitol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00884	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00422	0.0471	CbGpPWpGaD
Paricalcitol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00877	CcSEcCtD
Paricalcitol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00863	CcSEcCtD
Paricalcitol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00848	CcSEcCtD
Paricalcitol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00836	CcSEcCtD
Paricalcitol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00819	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00384	0.00799	CcSEcCtD
Paricalcitol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00793	CcSEcCtD
Paricalcitol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00787	CcSEcCtD
Paricalcitol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00782	CcSEcCtD
Paricalcitol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00779	CcSEcCtD
Paricalcitol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00772	CcSEcCtD
Paricalcitol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00366	0.00762	CcSEcCtD
Paricalcitol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00363	0.00756	CcSEcCtD
Paricalcitol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0075	CcSEcCtD
Paricalcitol—Pain—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0075	CcSEcCtD
Paricalcitol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00723	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00717	CcSEcCtD
Paricalcitol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00697	CcSEcCtD
Paricalcitol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00693	CcSEcCtD
Paricalcitol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00693	CcSEcCtD
Paricalcitol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00646	CcSEcCtD
Paricalcitol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00629	CcSEcCtD
Paricalcitol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00298	0.0062	CcSEcCtD
Paricalcitol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00288	0.006	CcSEcCtD
Paricalcitol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00279	0.0058	CcSEcCtD
Paricalcitol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00557	CcSEcCtD
Paricalcitol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00553	CcSEcCtD
Paricalcitol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00552	CcSEcCtD
Paricalcitol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00549	CcSEcCtD
Paricalcitol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00521	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—SPP1—nephrolithiasis	0.00154	0.0172	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GRHPR—nephrolithiasis	0.00119	0.0133	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AGXT—nephrolithiasis	0.00106	0.0118	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GRHPR—nephrolithiasis	0.000952	0.0106	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APRT—nephrolithiasis	0.000903	0.0101	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC26A1—nephrolithiasis	0.000903	0.0101	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AGXT—nephrolithiasis	0.000849	0.00947	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC26A1—nephrolithiasis	0.000722	0.00805	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APRT—nephrolithiasis	0.000722	0.00805	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000685	0.00764	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AQP1—nephrolithiasis	0.000643	0.00718	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CHRM3—nephrolithiasis	0.000582	0.00649	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AQP1—nephrolithiasis	0.000514	0.00574	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CHRM3—nephrolithiasis	0.000465	0.00519	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000155	0.00173	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000138	0.00154	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000117	0.00131	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000117	0.00131	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AQP1—nephrolithiasis	8.35e-05	0.000932	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CHRM3—nephrolithiasis	7.55e-05	0.000842	CbGpPWpGaD
